about
S-nitrosylation of FLICE inhibitory protein determines its interaction with RIP1 and activation of NF-kappa BHyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cellsPharmacological manipulation of cell death: clinical applications in sight?CD95 promotes tumour growthTherapeutic potential of snake venom in cancer therapy: current perspectivesInterferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytesBiological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspectiveHuman inhibitor of apoptosis proteins: why XIAP is the black sheep of the familyResponse rate of fibrosarcoma cells to cytotoxic drugs on the expression level correlates to the therapeutic response rate of fibrosarcomas and is mediated by regulation of apoptotic pathwaysCancer drug resistance: redox resetting renders a wayExploring Reovirus Plasticity for Improving Its Use as Oncolytic VirusIdentification of midkine as a mediator for intercellular transfer of drug resistanceArtesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cellsTumor selective cytotoxic action of a thiomorpholin hydroxamate inhibitor (TMI-1) in breast cancerPhosphorylated IκBα predicts poor prognosis in activated B-cell lymphoma and its inhibition with thymoquinone induces apoptosis via ROS releaseTargeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma.In vivo overexpression of X-linked inhibitor of apoptosis protein protects against neomycin-induced hair cell loss in the apical turn of the cochlea during the ototoxic-sensitive period.Apoptotic regulation of epithelial cellular extrusionApoptosis induction in Jurkat cells and sCD95 levels in women's sera are related with the risk of developing cervical cancerHeterogeneous in vitro effects of doxorubicin on gene expression in primary human liposarcoma culturesRNA silencing of Mcl-1 enhances ABT-737-mediated apoptosis in melanoma: role for a caspase-8-dependent pathway.Rational design of non-resistant targeted cancer therapiesEstrogen regulation of apoptosis in osteoblastsSurvival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFκB survival axis downstream of Death receptor-3.Mitochondria regulate DNA damage and genomic instability induced by high LET radiation.Phloroglucinol induces apoptosis through the regulation of insulin-like growth factor 1 receptor signaling pathways in human colon cancer HT-29 cells.Rocaglamide sensitizes leukemic T cells to activation-induced cell death by differential regulation of CD95L and c-FLIP expression.Rocaglamide breaks TRAIL resistance in HTLV-1-associated adult T-cell leukemia/lymphoma by translational suppression of c-FLIP expression.Phosphoprotein enriched in astrocytes (PEA)-15: a potential therapeutic target in multiple disease states.Kaposi's sarcoma herpesvirus microRNAs target caspase 3 and regulate apoptosis.Phloroglucinol induces apoptosis via apoptotic signaling pathways in HT-29 colon cancer cells.Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic leukaemia patients.Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapiesThe many roles of FAS receptor signaling in the immune systemGastric cancer cell supernatant causes apoptosis and fibrosis in the peritoneal tissues and results in an environment favorable to peritoneal metastases, in vitro and in vivo.TRAIL in cancer therapy: present and future challenges.Snake venom toxin from Vipera lebetina turanica induces apoptosis of colon cancer cells via upregulation of ROS- and JNK-mediated death receptor expressionPerturbations of cell cycle control in T cells contribute to the different outcomes of simian immunodeficiency virus infection in rhesus macaques and sooty mangabeysFenretinide-dependent upregulation of death receptors through ASK1 and p38α enhances death receptor ligand-induced cell death in Ewing's sarcoma family of tumours.Prognostic value of serum soluble Fas in patients with locally advanced unresectable rectal cancer receiving concurrent chemoradiotherapy
P2860
Q23921468-7071CE0F-A920-4A22-8D61-4684E8F7F940Q24319922-450B0E49-A913-4A02-8C17-CCA4D4B05D7AQ24536101-96FE22AE-68D8-425A-855E-C492383D3D7DQ24602589-CC1CFCC0-5C4B-4621-80E1-EB967D40FE8BQ24633814-29F178EB-6472-4E71-A2DC-F8DAA20AB447Q24646670-E06F0C07-18BF-4E9D-A980-9AF13126C9F3Q24658389-864A4794-BD5D-4ED7-93EB-F0B5F89298C0Q24670396-C4CEA21C-E24B-41B5-BDB7-DE4163DB3463Q24810525-D9B7F476-9941-49A7-9305-E34A8289A0EDQ26750753-FC1ABDBA-9469-4EAA-A265-3C4F50272B01Q26771799-C9C3DFB0-457E-4EE2-9FEA-2C231F382C9DQ28251166-57F7DC2C-FCB8-46EF-B053-100F306166E6Q28469266-567302C7-C5FD-4B68-B4B9-FDBAF43CB81CQ28483867-E2C0263C-949F-452E-BCF8-B7CE8E0B5E65Q28489100-960A9EDD-0264-4730-A914-158B5E559857Q30539569-C519ACF6-9C94-4BCE-9168-28664F30CFB2Q30587116-196F972A-F5D6-4508-A6EE-1F3178AF5980Q30638314-8D6DEFFF-05D0-4F58-9EC0-C73AFA302E2BQ33327764-C4410011-F4E5-4F50-8052-B97C5C6DBC48Q33380436-FE40B645-97A2-4D7E-AB69-76EDB1C8034EQ33494047-6210CFA6-A88B-4DB8-8DF0-55B56563C78AQ33594692-A9FA3FD0-6DDA-4245-9FE8-6E197B67E9BAQ33675169-1281D47D-8427-4C1F-8E9C-120BFD92BF63Q33948715-FB74926F-9A08-4509-91C8-B07D95DEAF00Q33951437-67A1797D-7DC4-4EA3-A929-7D2007E83D13Q34000553-F3E48C87-4D0A-4B3E-B3A4-C9D1D300E332Q34017088-80F25525-7EDF-4FBA-9389-7084785561D7Q34023467-4ADCA2BE-AF4F-4DC9-A9B0-2D601AF0D627Q34024181-0D7B0492-D335-462E-A337-BAB01A137C58Q34102689-539D66D2-F35C-4031-AAFF-757AE14FF53BQ34105203-6651341E-9185-41AF-96E0-89B73E497A4AQ34122737-CF03CD16-388A-4BC2-86AF-36AC52275ABCQ34158454-81CFA4F8-7AF8-4784-8D67-1601AA8C46FDQ34205697-D56689BB-3344-4F46-BFAE-AE449D155607Q34240700-259B0F97-050B-4C09-A7FE-D35212F207F4Q34291312-58EA5744-AB16-4BDA-B5E7-75C986C75727Q34297762-37EF27DE-C0DD-4055-BBEE-66DDFA7DCDECQ34301788-7F1733D6-08A6-45EC-9673-A6C10E66DB4AQ34344093-62F050BB-4BF9-49EE-BD50-691ACF2DCE5EQ34381899-CAF44B7F-CC40-494F-B8C2-C53DF03FEFAE
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Death receptors in chemotherapy and cancer.
@ast
Death receptors in chemotherapy and cancer.
@en
type
label
Death receptors in chemotherapy and cancer.
@ast
Death receptors in chemotherapy and cancer.
@en
prefLabel
Death receptors in chemotherapy and cancer.
@ast
Death receptors in chemotherapy and cancer.
@en
P2860
P356
P1433
P1476
Death receptors in chemotherapy and cancer.
@en
P2093
Peter H Krammer
P2860
P2888
P304
P356
10.1038/SJ.ONC.1207558
P407
P577
2004-04-01T00:00:00Z